Role of weekly paclitaxel in the treatment of advanced ovarian cancer-Reference-Cited by-同舟云学术

Role of weekly paclitaxel in the treatment of advanced ovarian cancer

Published:2002-12 Issue: Volume:44 Page:43-51
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Thomas Hilary,Rosenberg Per

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference42 articles.

1. Up date in the management of advanced ovarian carcinoma;Conte;Crit. Rev. Oncol. Hematol.,1999

2. Chemotherapy of advanced ovarian cancer;McGuire;Semin. Oncol.,1998

3. The integration of paclitaxel and new platinum compounds in the treatment of advanced cancer;Vermorken;Int. J. Gynecol. Cancer.,2001

4. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med.,1996

5. Long-term follow-up of GOG-111: a randomized trial comparing cisplatin combined with cyclophosphamide or paclitaxel in patients with stage III or IV epithelial ovarian cancer;McGuire;Int. J. Gynecol. Cancer.,1999

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reassessing specificity/selectivity of taxane-based chemotherapy;Cancer Insight;2023-11-29

2. Reassessing specificity/selectivity of taxane-based chemotherapy;Cancer Insight;2023-11-29

3. Metronomic Chemotherapy in Prostate Cancer;Journal of Clinical Medicine;2022-05-18

4. Efficacy of weekly paclitaxel for the treatment of advanced ovarian cancer;Medicine;2020-06-19

5. Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer;International Journal of Environmental Research and Public Health;2020-03-26